nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant Chemotherapy Is Associated With Improved Overall Survival in Locally Advanced Rectal Cancer After Achievement of a Pathologic Complete Response to Chemoradiation
|
Shahab, Danish |
|
2017 |
16 |
4 |
p. 300-307 |
artikel |
2 |
A Dose-finding and Biomarker Evaluation Phase Ib Study of Everolimus in Association With 5-Fluorouracil and Pelvic Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Cancer (E-LARC Study)
|
Gelsomino, Fabio |
|
2017 |
16 |
4 |
p. 410-415.e1 |
artikel |
3 |
A Practical Approach to Fatigue Management in Colorectal Cancer
|
Aapro, Matti |
|
2017 |
16 |
4 |
p. 275-285 |
artikel |
4 |
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer?
|
Rossi, Sabrina |
|
2017 |
16 |
4 |
p. 264-274 |
artikel |
5 |
Comparative Effectiveness Research: The Impact of Biologic Agents in Ethnic Minorities With Metastatic Colorectal Cancer
|
Goel, Sanjay |
|
2017 |
16 |
4 |
p. 286-292 |
artikel |
6 |
Comparing Clinical Characteristics and Outcomes of Young-onset and Late-onset Colorectal Cancer: An International Collaborative Study
|
Rho, Young Soo |
|
2017 |
16 |
4 |
p. 334-342 |
artikel |
7 |
Early-onset Colorectal Cancer is Distinct From Traditional Colorectal Cancer
|
Yeo, Heather |
|
2017 |
16 |
4 |
p. 293-299.e6 |
artikel |
8 |
Early Postoperative FDG-PET-CT Imaging Results in a Relevant Upstaging in the pN2 Subgroup of Stage III Colorectal Cancer Patients
|
Fehr, Martin |
|
2017 |
16 |
4 |
p. 343-348 |
artikel |
9 |
Editorial Board
|
|
|
2017 |
16 |
4 |
p. A1 |
artikel |
10 |
Effectiveness of Screening Modalities in Colorectal Cancer: A Network Meta-Analysis
|
Zhang, Jianping |
|
2017 |
16 |
4 |
p. 252-263 |
artikel |
11 |
Feasibility and Efficacy of Presurgical Exercise in Survivors of Rectal Cancer Scheduled to Receive Curative Resection
|
Singh, Favil |
|
2017 |
16 |
4 |
p. 358-365 |
artikel |
12 |
FOLFOXIRI Regimen for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
|
Leal, Frederico |
|
2017 |
16 |
4 |
p. 405-409.e2 |
artikel |
13 |
Hepatic Arterial Infusion Chemotherapy for Unresectable Liver Metastases of Colorectal Cancer: A Multicenter Retrospective Study
|
Lim, Annie |
|
2017 |
16 |
4 |
p. 308-315 |
artikel |
14 |
HER2 as an Emerging Oncotarget for Colorectal Cancer Treatment After Failure of Anti-Epidermal Growth Factor Receptor Therapy
|
Takegawa, Naoki |
|
2017 |
16 |
4 |
p. 247-251 |
artikel |
15 |
Multidisciplinary Clinics for Colorectal Cancer Care Reduces Treatment Time
|
Kozak, Vanessa N. |
|
2017 |
16 |
4 |
p. 366-371 |
artikel |
16 |
Neurotoxicity Outcomes in a Population-based Cohort of Elderly Patients Treated With Adjuvant Oxaliplatin for Colorectal Cancer
|
Raphael, Michael J. |
|
2017 |
16 |
4 |
p. 397-404.e1 |
artikel |
17 |
Predictive Value of Early Tumor Shrinkage and Density Reduction of Lung Metastases in Patients With Metastatic Colorectal Cancer Treated With Regorafenib
|
Vanwynsberghe, Hannes |
|
2017 |
16 |
4 |
p. 377-380 |
artikel |
18 |
Real-world Direct Health Care Costs for Metastatic Colorectal Cancer Patients Treated With Cetuximab or Bevacizumab-containing Regimens in First-line or First-line Through Second-line Therapy
|
Johnston, Stephen |
|
2017 |
16 |
4 |
p. 386-396.e1 |
artikel |
19 |
REOX: Evaluation of the Efficacy of Retreatment With an Oxaliplatin-containing Regimen in Metastatic Colorectal Cancer: A Retrospective Single-center Study
|
Costa, Talita |
|
2017 |
16 |
4 |
p. 316-323 |
artikel |
20 |
Significance of Anemia in Outcomes After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
|
McGrane, John M. |
|
2017 |
16 |
4 |
p. 381-385 |
artikel |
21 |
Stereotactic Robotic Body Radiotherapy for Patients With Unresectable Hepatic Oligorecurrence
|
Berkovic, Patrick |
|
2017 |
16 |
4 |
p. 349-357.e1 |
artikel |
22 |
Table of contents
|
|
|
2017 |
16 |
4 |
p. A3-A6 |
artikel |
23 |
Treatment of Patients With Metastatic Colorectal Cancer in a Real-World Scenario: Probability of Receiving Second and Further Lines of Therapy and Description of Clinical Benefit
|
Tampellini, Marco |
|
2017 |
16 |
4 |
p. 372-376 |
artikel |
24 |
Volumetric Versus Unidimensional Measures of Metastatic Colorectal Cancer in Assessing Disease Response
|
Lubner, Meghan G. |
|
2017 |
16 |
4 |
p. 324-333.e1 |
artikel |